Dafna Capital Management LLC Cyma Bay Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

$389 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$3.22 - $6.27 $4.93 Million - $9.61 Million	-1,532,176 Reduced 89.96%	171,059 $1.07 Million
Q3 2022 Nov 14, 2022	SELL	$2.77 - $4.25 $233,605 - $358,419	-84,334 Reduced 4.72%	1,703,235 $5.96 Million
Q2 2022 Aug 15, 2022	BUY	$1.72 - $3.39 $163,400 - $322,050	95,000 Added 5.61%	1,787,569 $5.27 Million
Q1 2022 May 16, 2022	SELL	$2.77 - $3.64 $263,150 - $345,800	-95,000 Reduced 5.31%	1,692,569 $5.26 Million
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $4.08 Million - $5.81 Million	1,263,283 Added 240.95%	1,787,569 $6.04 Million
Q3 2021 Nov 15, 2021	BUY	$3.47 - $4.42 $48,233 - $61,438	13,900 Added 2.72%	524,286 $1.91 Million
Q2 2021 Aug 16, 2021	BUY	$3.94 - $4.92 $680,107 - $849,270	172,616 Added 51.1%	510,386 $2.23 Million
Q1 2021 May 17, 2021	BUY	$4.23 - $6.55 $1.43 Million - $2.21 Million	337,770 New	337,770 $1.53 Million
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $549,792 - $1.2 Million	-165,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $233,496 - $703,800	165,600 New	165,600 $578,000
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $465,494 - $2.08 Million	-349,996 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $430,669 - $972,387	71,185 Added 25.53%	349,996 $2.51 Million
Q1 2019 May 15, 2019	SELL	$8.16 - $13.42 $438,192 - $720,654	-53,700 Reduced 16.15%	278,811 $3.7 Million
Q4 2018 Feb 14, 2019	BUY	$6.54 - $11.74 $248,520 - $446,120	38,000 Added 12.9%	332,511 $2.62 Million
Q2 2018 Aug 13, 2018	SELL	$10.66 - $14.38 $312,679 - $421,794	-29,332 Reduced 9.06%	294,511 $3.95 Million
Q1 2018 May 15, 2018	SELL	$9.0 - $15.16 $335,889 - $565,786	-37,321 Reduced 10.33%	323,843 $4.21 Million
Q4 2017 Feb 14, 2018	SELL	$7.67 - $9.31 $566,322 - $687,413	-73,836 Reduced 16.97%	361,164 $3.32 Million
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $2.59 Million - $3.59 Million	435,000	435,000 $3.51 Million

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account